ClinicalTrials.gg
CompletedNCT05041985Updated Dec 4, 2024

Clinical Efficacy of Diazepam After Whiplash

A Phase 4 interventional study of Diazepam Tablets in Whiplash Injuries and Whiplash Injury of Cervical Spine, sponsored by Edin Mešanović. Completed at 1 site in Bosnia and Herzegovina. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-04.

Sponsored by Edin Mešanović · Phase 4, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jan 2020, registered Sep 2021).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
89
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Whiplash injury is very common and lot of patients which suffered the injury have chronic symptoms despite different treatment options. One of main symptoms include muscle spasm and pain caused by neck movement. Diazepam is a well known drug which can be used to treat muscle spasms. The aim of this study is to determine whether short term Diazepam therapy can have positive effect on long term outcomes after whiplash injury.

Read the detailed description

This randomized, assessor-blinded study was conducted on patients presented due to a cervical spine injury caused by a traffic accident in the previous 48 hours from 1st January 2020 to 31st December 2020. All the patient which were included in this study were divided into 2 groups: group A, the Test group, and group B, the control group. All patients signed the consent to participate in the study prior to randomization. During the initial examination a detailed history was taken and it included Visual Analog Pain Scale (VAS). On follow up examinations 7 days, 6 weeks and 6 months after the injury, all patients completed Neck disability index (NDI), Whiplash disability questionnaire (WDQ) as well as Visual Analog Pain Scale (VAS). Any patient which didn't complete all the follow up examination was excluded from the study.

02

Conditions studied

  • Whiplash Injuries
  • Whiplash Injury of Cervical Spine

Keywords

  • whiplash
  • cervical spine
  • neck
  • whiplash injury
  • muscle spasm
  • diazepam
  • muscle strain
03

In context

Whiplash Injuries

62 studies on the registry are indexed under Whiplash Injuries; 9 are open to participants now.

This study's enrollment of 89 is above the median of 61 across 44 interventional studies indexed under Whiplash Injuries.

Browse Whiplash Injuries studies →

Lead sponsor

Edin Mešanović is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients who suffered cervical spine injury caused by a traffic accident in the previous 48 hours

Exclusion criteria

Exclusion Criteria:

  • younger than 18 years of age; older than 70 years of age; the presence of associated injuries; previous surgery on the cervical spine; previously diagnosed arthrosis of the cervical spine; the presence of a malignant process and previous cervical spine injuries; history of Diazepam allergy
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
89 participants (actual)

Study arms

  • Experimental
    group A (the Test group)

    arm which received Diazepam 5 mg therapy for 7 days after whiplash

    Drug: Diazepam Tablets

  • No intervention
    group B (the control group)

    a group which did not receive Diazepam 5 mg therapy

Interventions

06

What researchers measure

Primary outcomes

  1. change in Whiplash Disability Questionnaire score 6 months after injury (0-130; 0 no disability, 130 maximal disability)

    Comparation of same score at the follow up examination 7 days after the injury

    Time frame: 6 months

  2. change in Neck Disability Index score 6 months after injury (0-50, 0 - no disability 50 maximal disability)

    Comparation of same score at the follow up examination 7 days after the injury

    Time frame: 6 months

Secondary outcomes

  1. changes in Visual Analog Scale scores 7 days after the injury (0-10; 0-no pain 10 maximum pain level)

    Comparation of same score at the initial examination after the injury

    Time frame: 7 days

  2. changes in Visual Analog Scale scores 6 weeks after the injury (0-10; 0-no pain 10 maximum pain level)

    Comparation of same score at the initial examination after the injury

    Time frame: 6 weeks

  3. changes in Visual Analog Scale scores 6 months after the injury (0-10; 0-no pain 10 maximum pain level)

    Comparation of same score at the initial examination after the injury

    Time frame: 6 months

  4. change in Whiplash Disability Questionnaire score 6 weeks after injury (0-130; 0 no disability, 130 maximal disability)

    Comparation of same score at the follow up examination 7 days after the injury

    Time frame: 6 weeks

  5. change in Neck Disability Index score 6 weeks after injury (0-50, 0 - no disability 50 maximal disability)

    Comparation of same score at the follow up examination 7 days after the injury

    Time frame: 6 weeks

07

Study locations

1 site
  • KB "dr.Safet Mujic"
    Mostar, HNK 88000, Bosnia and Herzegovina
08

References and documents

Publications

  • Spitzer WO, Skovron ML, Salmi LR, Cassidy JD, Duranceau J, Suissa S, Zeiss E. Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management. Spine (Phila Pa 1976). 1995 Apr 15;20(8 Suppl):1S-73S. No abstract available. Erratum In: Spine 1995 Nov 1;20(21):2372. PubMed 7604354 ↗
  • Uehara Benites MA, Perez-Garrigues H, Morera Perez C. [Clinical symptoms of equilibrium disorders in patients with whiplash syndrome]. Acta Otorrinolaringol Esp. 2009 May-Jun;60(3):155-9. Spanish. PubMed 19558900 ↗
  • Tanaka N, Atesok K, Nakanishi K, Kamei N, Nakamae T, Kotaka S, Adachi N. Pathology and Treatment of Traumatic Cervical Spine Syndrome: Whiplash Injury. Adv Orthop. 2018 Feb 28;2018:4765050. doi: 10.1155/2018/4765050. eCollection 2018. PubMed 29682354 ↗
  • Benoist M, Rouaud JP. Whiplash: myth or reality? Joint Bone Spine. 2002 Jun;69(4):358-62. doi: 10.1016/s1297-319x(02)00410-4. No abstract available. PubMed 12184430 ↗

Individual participant data

Plan to share: Yes — I am ready to share all IPD that underlie results in a publication

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: I would be ready to share the IPD after publication.

Access criteria: I would like to be included in process of who is getting the IPD.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2020 to primary completion in Dec 2020, 11 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 4, 2021
First posted
Sep 13, 2021
StartActual
Jan 1, 2020
Primary completionActual
Dec 31, 2020
CompletionActual
Dec 31, 2020
Last update
Dec 4, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05041985
Lead sponsor
Edin Mešanović
Responsible party
Edin Mešanović (orthopedic surgeon, Cantonal Hospital Dr. Safet Mujic Mostar) — Sponsor-investigator
First posted
Sep 13, 2021
Start date
Jan 1, 2020
Primary completion
Dec 31, 2020
Completion
Dec 31, 2020
Last update
Dec 4, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Diazepam

Start the discussion